Christin Melton

Authored Items
A Review of Investigational Drugs at HOPA
Christin Melton
TOP - MAY 2011, VOL 4, NO 3 in Conference Correspondent
Review of New Oncology Drugs at HOPA
Christin Melton
TOP - March/April 2011, VOL 4, NO 2 in Conference Correspondent
Cost-Containment Strategies
Christin Melton
TOP - March/April 2011, VOL 4, NO 2 in Conference Correspondent
Making Cancer Drugs Worth the Cost
Christin Melton
TOP - March/April 2011, VOL 4, NO 2
Are You Talking to Patients About Smoking Cessation?
Christin Melton
TOP - March/April 2011, VOL 4, NO 2 in Conference Correspondent
Drug Shortages: A Growing Crisis in Oncology
Christin Melton
TOP - March/April 2011, VOL 4, NO 2 in Drug Updates
FDA Panel Recommends Stricter Process for Accelerated Approval of Cancer Drugs
Christin Melton
TOP - March/April 2011, VOL 4, NO 2 in In the News
Ipilimumab (Yervoy) Is First Melanoma Drug Approved in a Decade
Christin Melton
TOP - March/April 2011, VOL 4, NO 2 in Skin Cancer
Considerations for Cancer Treatment–Induced Diarrhea
Christin Melton
TOP - March/April 2011, VOL 4, NO 2 in Supportive Care
Managing Elderly Patients Who Have Comorbidities
Christin Melton
TOP - March/April 2011, VOL 4, NO 2 in Supportive Care
Medicare Plans to Cover Provenge
Christin Melton
TOP - March/April 2011, VOL 4, NO 2 in Genitourinary Cancers
Variation in Prescribing Instructions Confuses Patients on Multidrug Regimens
Christin Melton
TOP - March/April 2011, VOL 4, NO 2 in Practical Issues for Pharmacists
ASCO Calls for EGFR Mutation Testing in Some Patients with Lung Cancer
Christin Melton
TOP - Daily
Considerations for Cancer-treatment–Induced Diarrhea
Christin Melton
TOP - Daily
Medicare Says Agency Plans to Cover Provenge
Christin Melton
TOP - Daily
Ipilimumab (Yervoy) Becomes First Melanoma Drug Approved in a Decade
Christin Melton
TOP - Daily in Conference Correspondent
NCCN Updates Guidelines on Breast Cancer Treatment
Christin Melton
TOP - Daily in Breast Cancer
Incyte Will Seek Approval of Ruxolitinib in Myelofibrosis Based on Positive Phase III Data
Christin Melton
TOP - Daily in Cancer Center Profile
Novel SRC Inhibitor Might Help Overcome Trastuzumab Resistance in Breast Cancer
Christin Melton
TOP - Daily in Breast Cancer
Fish Oil May Prevent Muscle Loss in Cancer Patients Undergoing Chemotherapy
Christin Melton
TOP - Daily
Ovarian Cancer Treatment for Medicare Patients Often Falls Short of Guidelines
Christin Melton
TOP - Daily
Eribulin Improves Overall Survival in Women with Heavily Pretreated Metastatic Breast Cancer
Christin Melton
TOP - Daily in Breast Cancer
FDA Sets June Date to Hear Genentech's Arguments for Use of Avastin in Breast Cancer
Christin Melton
TOP - Daily
Intermittent Androgen Suppression Recommended as New Standard in Recurrent Prostate Cancer
Christin Melton
TOP - Daily in Genitourinary Cancers
Balloon Kyphoplasty Associated with Less Pain and Greater Mobility
Christin Melton
TOP - Daily
Crizotinib New Drug Application Fast-Tracked by the FDA
Christin Melton
TOP - Daily
FDA Panel Recommends Stricter Process for Accelerated Approval of Cancer Drugs
Christin Melton
TOP - Daily
FDA Approves Mobile MIM Radiology Application for Portable Devices
Christin Melton
TOP - Daily
Last modified: February 7, 2011